Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-25-032066
Filing Date
2025-04-15
Accepted
2025-04-15 16:01:02
Documents
79
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT ea0237960-10q_advanced.htm   iXBRL 10-Q 744111
2 CERTIFICATION ea023796001ex31-1_advan.htm EX-31.1 10115
3 CERTIFICATION ea023796001ex31-2_advan.htm EX-31.2 10519
4 CERTIFICATION ea023796001ex32-1_advan.htm EX-32.1 3990
5 CERTIFICATION ea023796001ex32-2_advan.htm EX-32.2 4015
  Complete submission text file 0001213900-25-032066.txt   4962787

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE advb-20241231.xsd EX-101.SCH 48485
7 XBRL CALCULATION FILE advb-20241231_cal.xml EX-101.CAL 39643
8 XBRL DEFINITION FILE advb-20241231_def.xml EX-101.DEF 227920
9 XBRL LABEL FILE advb-20241231_lab.xml EX-101.LAB 358485
10 XBRL PRESENTATION FILE advb-20241231_pre.xml EX-101.PRE 238348
82 EXTRACTED XBRL INSTANCE DOCUMENT ea0237960-10q_advanced_htm.xml XML 569946
Mailing Address 401 RYLAND ST STE 200-A RENO NV 89502
Business Address 401 RYLAND ST STE 200-A RENO NV 89502 86-21-20510823
Advanced Biomed Inc. (Filer) CIK: 0001941029 (see all company filings)

EIN.: 000000000 | State of Incorp.: NV
Type: 10-Q | Act: 34 | File No.: 001-42548 | Film No.: 25839422
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)